retatrutide phase 2 trial results weight loss of a new medication, Retatrutide, showed the highest amount of in a clinical so far. 24% of body weight lost. An average of 58 pounds over 48 weeks! The medical management of a 9-week trip on retatrutide

10.1038/ng.2982 39 SpragueB

Watch your bodys dashboard, not just the scale

PlexusDx providers screen for contraindications before starting therapy, including personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2

Two groups received consistent weekly doses of 0.3 mg and 0.6 mg throughout the 26-week study, while three groups saw their dosages escalated every two weeks to reach 1.2, 2.4, and 4.5 mg/week

The hormonal tests were also somewhat different LH pulses were measured again, but this time response to naloxone was measured

The safety considerations for any peptide or medication involve weighing benefits against risks for each individual patient